Onglyza | The American Association For Justice

Onglyza

Description:

Onglyza and Kombiglyze XR are type 2 diabetes drugs manufactured and sold by Bristol-Meyers Squibb Company and AstraZeneca Pharmaceuticals LP. A 2014 FDA study showed that patients taking Onglyza had a higher risk of potentially fatal heart failure. In 2016, the FDA added a stronger warning on Onglyza's label.  

The Onglyza Litigation Group provides a forum for sharing information, ideas, and materials, while educating members. Members will receive the most up to date information about the litigation, science, and injuries.

Background:

This Litigation Group was formed in February 2018.

Benefits & Resources:

The Onglyza Heart Failure Litigation Group provides a forum for lawyers litigating cases to share knowledge, strategies, and educational resources. The Litigation Group has a secure, members-only list server and document library where members can share pertinent information and documents regarding the litigation. This Litigation Group holds regular meetings that are closed to members only to discuss current cases and important updates. 

Meetings:

AAJ Annual and Winter Conventions, or as need by group members.

Membership:
Open to AAJ Regular, Life, Sustaining, President's Club, and Leaders Forum members.
Cochairs:
Timothy M. Clark
Sanders Phillips Grossman, LLC
2860 Michelle, Suite 220
Irving, CA 92606
Phone: 877/480-9142
 
Jennifer Moore
Grossman & Moore, PLLC
401 W. Main St., Ste. 1810
Louisville, KY 40202
Phone: 502/657-7100
Dues:
$300/attorney, $100/additional member ($400 max)